title: Hepatitis A vaccination in chronic carriers of hepatitis B virus.
abstract: Because hepatitis A infection may be more severe in patients with chronic liver disease, we vaccinated 33 children who were chronic HBsAg carriers against hepatitis A virus. Anti-hepatitis A virus seroconversion rates after the first, second, and third doses were 90.9%, 96.9%, and 100%, respectively.
authors.affiliation: First Pediatric Clinic and Institute of Virology, University of Milan, Milan, Italy; Department of Infectious diseases, G. Gaslini Children's Hospital of Genoa, Genoa, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Nebbia
authors.forename: R
authors.initials: R
authors.lastname: Giacchino
authors.forename: R
authors.initials: R
authors.lastname: Soncini
authors.forename: V
authors.initials: V
authors.lastname: Ramaccioni
authors.forename: A
authors.initials: A
authors.lastname: Timitilli
authors.forename: A R
authors.initials: AR
authors.lastname: Zanetti
mesh_terms: D000293:Adolescent; D002353:Carrier State; D002648:Child; D002675:Child, Preschool; D005260:Female; D006506:Hepatitis A / Q000276:immunology / Q000517:prevention & control*; D022362:Hepatitis A Vaccines; D006514:Hepatitis B Surface Antigens / Q000032:analysis*; D006515:Hepatitis B virus / Q000276:immunology*; D019694:Hepatitis B, Chronic / Q000276:immunology*; D006801:Humans; D008297:Male; D014611:Vaccination; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage* / Q000276:immunology
chemical_list: D022362:Hepatitis A Vaccines; D006514:Hepatitis B Surface Antigens; D014761:Viral Hepatitis Vaccines